Front Cell Dev Biol (2021) 9:696542
The peptide modulates nitric oxide synthase levels, reducing chronic inflammation across joint and soft tissue injury models
Scenario 3: metabolic health focus (weight is secondary to biomarkers) Starting point: prediabetes, insulin resistance, metabolic syndrome, or family history of type 2 diabetes
doi: 10.1080/02640414.2011.614269
I would frame these findings as hypothesis-generating and clinically important, but not definitive proof that GLP-1 therapy directly caused the reductions we observed, Sheer says
Unlike vitamins C or E, which must be obtained through the diet, glutathione is synthesized directly within our cells